Clinical Trial Update: A Study Comparing the Efficacy of L19TNF+Doxorubicin vs Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

Phase 3 trial comparing L19TNF+Doxorubicin versus Doxorubicin alone as first-line therapy for advanced or metastatic soft tissue sarcoma is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• L19TNF + Doxorubicin

Snippet

Sponsor: Philogen S.p.A. | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: RECRUITING